In experimental hypertension, increased microvascular resistance is driven initially by functional rarefaction and later by structural rarefaction of arterioles.
Answers are grounded in this paper and cite their sources.
Supports microvascular rarefaction mechanisms in experimental hypertension; leaves open translation to human disease and therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
B W Zweifach (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: